Navy submarine to tap undersea cables capability revealed
Intelligence experts say the USS Timmy Carter will join the Seawolf class with covert undersea cable tapping abilities. Navy officials deny commenting on the 3.8 billion dollar submarine and its classified functions, while watchdogs expect further confirmation in coming months.
MENTIONED IN THIS ARTICLE
Washington
Timmy Carter
Navy
Kevin Sykes
Islamic Ashoura Attacks Shake Shiite Mosques in Baghdad
Five sudden incidents struck Shiite mosques and streets in Baghdad and Iskandariyah on Ashoura eve as Shiite politicians debated candidates for prime minister. Officials blamed Sunni insurgents while leaders urged restraint, vows to pursue power peacefully, and to prevent sectarian violence.
MENTIONED IN THIS ARTICLE
Jamie Tarabay
Associated Press
Maghdad
Iraq
Shlite
Pentagon
Ahmad Chalabi
Preas
Ibrahim al Jaafari
Baghdad
Iskandariyal
Shilas
Maslin
Osama bin Laden
Sari Abdullah
al-Khadimain
Data breach scandal prompts reform calls nationwide
San Francisco reports reveal ChoicePoint investigations into a yearlong data theft affecting up to 500000 people. Authorities say 709 identities were stolen this year as scammers used ChoicePoint client accounts. Regulators and consumer advocates push for federal oversight and stronger data safeguards amid disclosures of vast databases containing Social Security numbers and sensitive records.
MENTIONED IN THIS ARTICLE
San Francisco
Choice Point Inc
California
Bull
ChoicePoint
Los Angeles
ChaivePaint
Mlatunji Oluwatosin
Kinka's
Equifax
Nebraska fights trend toward segregated schools in Lexington
In Lexington Nebraska district superintendent Dick Eisenhauer laments white flight to outlying schools amid rising Hispanic enrollment tied to meatpacking jobs. State lawmakers weigh a plan to merge outlying elementary schools with larger K-12 districts, potentially closing small schools.
MENTIONED IN THIS ARTICLE
Nebraska
Sancoln
Neb
Dick Eisenhauer
Lexington
Ailenton
Paigishature
Sibirds
Restat
State
FDA panel backs Celebrex Bextra use amid heart risk debate
An FDA advisory panel concluded Celebrex and Bextra should remain available with strong warnings while urging long term studies. Vioxx posed the greatest risk and Merck eyed a relaunch. The panel split on Bextra and favored continued Celebrex sales despite safety concerns.
MENTIONED IN THIS ARTICLE
Washington
Priday
Merc & Co
Merck
FDA
Bextra
Alistair v
Wood
Vanderbilt University Medical School
Anleby
New York Stock Exchange
Also Mentioned on This Page
Rehnquist
Swabhington
William H. Rehnquist
Supreme Court
UNG Court
Hriday
Rehngiat
Kathy Arberg Sand
Leen
Ninaandy Cron
Harvard
Ambridge
Mass
Lawrence ‘Sumaers
Himgell
Wonten
Firestor i Ulat
Amd
James L. Watson
Umialogy
SUN
Broadway
Ashoura
Muharram
Imam Hussein
Muhammad
Karbala
Mouwaffaq al-Rubate
Abu Musab al-Zarqawi
Baath Party
Saddam Hussein
Walid AL Nilly
Daws Party
Al-Jazeera Television
Shilte Ash Shulah
Larry Ponemon
Tucson
Asia
James Lee
Themasi (Ag
Julia AR
WOMIE
Amipcas
Resaigy
Jalcaus
Neel
Satan
Constantine
Hitch
Nwinn-Diaie
Taos
Bale
Regal Cinemas
AVON
Laneane
Vlimls
Winn-Diniere
Apollo Theater
Samuel L. Jackson
Carter
Lear McA AD